These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 847396)

  • 1. The effect of phospholipase C on rat blood platelets in vivo.
    Giercksky KE
    Scand J Haematol; 1977 Mar; 18(3):219-25. PubMed ID: 847396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human platelet aggregation by phospholipase-A.
    Iatridis SG; Iatridis PG; Markidou SG; Ragatz BH
    Thromb Res; 1976 Oct; 9(4):335-44. PubMed ID: 982355
    [No Abstract]   [Full Text] [Related]  

  • 3. Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid.
    Packham MA; Livne AA; Ruben DH; Rand ML
    Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):849-56. PubMed ID: 8384448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet aggregation following exposure of phospholipase-treated platelet rich plasma to hydrogen peroxide.
    Iatridis SG; Iatridis PG; Kyrkou KA; Markidou SG; Iatridi IS
    Thromb Res; 1979; 15(5-6):733-41. PubMed ID: 494174
    [No Abstract]   [Full Text] [Related]  

  • 5. Carrageenan-induced activation of human platelets is independent of phospholipase A2 and of formation of thromboxanes.
    Vargaftig BB; Fouque F; Chignard M; Dumarey C
    J Pharm Pharmacol; 1980 Nov; 32(11):740-5. PubMed ID: 6110720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro and ex-vivo inhibition of blood platelet aggregation by naftazone.
    Durand P; Bloy C; Peltier-Pujol F; Blache D
    J Pharm Pharmacol; 1996 Jun; 48(6):566-72. PubMed ID: 8832488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of phospholipase C on human blood platelets.
    Otnaess AB; Holm T
    J Clin Invest; 1976 Jun; 57(6):1419-25. PubMed ID: 819457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creatine phosphate in rat platelets decreased by ADP or thrombin.
    Shibata S
    Thromb Haemost; 1979 Aug; 42(2):626-30. PubMed ID: 505370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The decrease in phosphatidylinositol 4,5-bisphosphate in ADP-stimulated washed rabbit platelets is not primarily due to phospholipase C activation.
    Vickers JD; Kinlough-Rathbone RL; Mustard JF
    Biochem J; 1986 Jul; 237(2):327-32. PubMed ID: 3026316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo functions of thrombin-treated platelets.
    Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
    Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphasic effect on platelet aggregation by phospholipase a purified from Vipera russellii snake venom.
    Teng CM; Chen YH; Ouyang C
    Biochim Biophys Acta; 1984 May; 772(3):393-402. PubMed ID: 6426517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the effects of phospholipase C on human platelets: evidence that aggregation induced by phospholipase C is independent of prostaglandin generation, released ADP and is modulated by cyclic AMP.
    Akbar H; Navran SS; Chang J; Miller DD; Feller DR
    Thromb Res; 1982 Aug; 27(4):405-17. PubMed ID: 6293114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects on platelet function of removal of platelet sialic acid by neuraminidase.
    Greenberg J; Packham MA; Cazenave JP; Reimers HJ; Mustard JF
    Lab Invest; 1975 Apr; 32(4):476-84. PubMed ID: 1127870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 2-tetradecylglycidic acid on rat platelet energy metabolism and aggregation.
    Ishikura H; Takeyama N; Tanaka T
    Biochim Biophys Acta; 1992 Oct; 1128(2-3):193-8. PubMed ID: 1420290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo release and clearance of rat platelet phospholipase A2.
    Murakami M; Kudo I; Inoue K
    Biochim Biophys Acta; 1989 Oct; 1005(3):270-6. PubMed ID: 2804056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rat.
    Clowes AW; Karnovsky MJ
    Lab Invest; 1977 Apr; 36(4):452-64. PubMed ID: 846193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that the rat is not an appropriate model to study the role of prostaglandins in normal or abnormal platelet aggregation.
    Huzoor-Akbar ; Anwer K
    Thromb Res; 1986 Feb; 41(4):555-66. PubMed ID: 3961734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatidic and lysophosphatidic acid production in phospholipase C-and thrombin-treated platelets. Possible involvement of a platelet lipase.
    Mauco G; Chap H; Simon MF; Douste-Blazy L
    Biochimie; 1978 Sep; 60(6-7):653-61. PubMed ID: 214164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.